JP2010528093A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010528093A5 JP2010528093A5 JP2010509847A JP2010509847A JP2010528093A5 JP 2010528093 A5 JP2010528093 A5 JP 2010528093A5 JP 2010509847 A JP2010509847 A JP 2010509847A JP 2010509847 A JP2010509847 A JP 2010509847A JP 2010528093 A5 JP2010528093 A5 JP 2010528093A5
- Authority
- JP
- Japan
- Prior art keywords
- cect
- strain
- deposited
- medicament
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 241000194032 Enterococcus faecalis Species 0.000 claims description 3
- 241000194029 Enterococcus hirae Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 3
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 102100037642 Elongation factor G, mitochondrial Human genes 0.000 claims description 2
- 101150016954 efg1 gene Proteins 0.000 claims description 2
- 101150100117 gfm1 gene Proteins 0.000 claims description 2
- 208000030770 patent ductus arteriosus 3 Diseases 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 12
- 239000006041 probiotic Substances 0.000 claims 11
- 235000018291 probiotics Nutrition 0.000 claims 11
- 230000000529 probiotic effect Effects 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 8
- 239000006228 supernatant Substances 0.000 claims 7
- 241001465754 Metazoa Species 0.000 claims 6
- 238000011282 treatment Methods 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 235000013336 milk Nutrition 0.000 claims 4
- 239000008267 milk Substances 0.000 claims 4
- 210000004080 milk Anatomy 0.000 claims 4
- 235000016709 nutrition Nutrition 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 239000000047 product Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 241000186012 Bifidobacterium breve Species 0.000 claims 2
- 206010061217 Infestation Diseases 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 210000005075 mammary gland Anatomy 0.000 claims 2
- 208000004396 mastitis Diseases 0.000 claims 2
- 241000894007 species Species 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 241000186840 Lactobacillus fermentum Species 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 210000003754 fetus Anatomy 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 210000004251 human milk Anatomy 0.000 claims 1
- 235000020256 human milk Nutrition 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 229940012969 lactobacillus fermentum Drugs 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 210000000664 rectum Anatomy 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
- 210000001215 vagina Anatomy 0.000 claims 1
- 230000035899 viability Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07380158.1 | 2007-05-31 | ||
| EP07380158A EP1997499A1 (en) | 2007-05-31 | 2007-05-31 | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
| PCT/EP2008/056768 WO2008145756A1 (en) | 2007-05-31 | 2008-06-02 | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010528093A JP2010528093A (ja) | 2010-08-19 |
| JP2010528093A5 true JP2010528093A5 (cg-RX-API-DMAC7.html) | 2011-07-21 |
| JP5710250B2 JP5710250B2 (ja) | 2015-04-30 |
Family
ID=38657070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509847A Active JP5710250B2 (ja) | 2007-05-31 | 2008-06-02 | 哺乳類乳汁微生物、それらを含有する組成物および乳腺炎の治療のためのそれらの使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8557560B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1997499A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5710250B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008257455B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2689360C (cg-RX-API-DMAC7.html) |
| CO (1) | CO6270334A2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2162143T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2555159T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE025851T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL202386A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009013044A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ581576A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2162143T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2162143E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2446814C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008145756A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010103132A1 (es) * | 2009-03-10 | 2010-09-16 | Hero España, S.A. | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| RU2476591C1 (ru) * | 2011-08-19 | 2013-02-27 | Федеральное государственное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | Штамм enterococcus hirae, используемый для приготовления кисломолочных продуктов |
| RU2477313C1 (ru) * | 2011-08-25 | 2013-03-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | ШТАММ Enterococcus hirae, ИСПОЛЬЗУЕМЫЙ ПРИ ПРОИЗВОДСТВЕ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ |
| RU2476592C1 (ru) * | 2011-09-02 | 2013-02-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | Штамм enterococcus hirae, используемый для производства кисломолочных продуктов |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| JP6203816B2 (ja) | 2012-03-29 | 2017-09-27 | セラバイオーム，エルエルシー | 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤 |
| CA3013541C (en) | 2013-03-14 | 2021-01-19 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| US20160066582A1 (en) | 2013-04-23 | 2016-03-10 | Terragen Holdings Limited | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same |
| DE102013105666A1 (de) | 2013-06-03 | 2014-12-04 | Hochschule Hannover | Probiotische Stämme, Zusammensetzungen enthaltend probiotische Stämme sowie pharmazeutische Mittel |
| EP2818056A1 (en) | 2013-06-25 | 2014-12-31 | Biosearch S.A. | Probiotic bacteria comprising metals, metal nanoparticles and uses thereof |
| US9390312B2 (en) | 2013-08-23 | 2016-07-12 | Elwha Llc | Systems, methods, and devices for assessing microbiota of skin |
| US20150057574A1 (en) | 2013-08-23 | 2015-02-26 | Elwha Llc | Selecting and Delivering Treatment Agents based on a Microbe Profile |
| US9811641B2 (en) | 2013-08-23 | 2017-11-07 | Elwha Llc | Modifying a cosmetic product based on a microbe profile |
| US9456777B2 (en) | 2013-08-23 | 2016-10-04 | Elwha Llc | Systems, methods, and devices for assessing microbiota of skin |
| US10152529B2 (en) | 2013-08-23 | 2018-12-11 | Elwha Llc | Systems and methods for generating a treatment map |
| US9805171B2 (en) | 2013-08-23 | 2017-10-31 | Elwha Llc | Modifying a cosmetic product based on a microbe profile |
| US9557331B2 (en) | 2013-08-23 | 2017-01-31 | Elwha Llc | Systems, methods, and devices for assessing microbiota of skin |
| US10010704B2 (en) | 2013-08-23 | 2018-07-03 | Elwha Llc | Systems, methods, and devices for delivering treatment to a skin surface |
| PT2862576T (pt) | 2013-10-16 | 2017-03-16 | Casen Recordati S L | Microrganismos e composições que os compreendem para utilização no tratamento ou prevenção de mastite |
| WO2015093937A1 (en) * | 2013-12-19 | 2015-06-25 | N.V. Nutricia | Lactobacillus salivarius for the treatment of mastitis |
| CN107073049B (zh) * | 2014-10-21 | 2021-12-14 | 阿曲龙Cyl有限公司 | 益生菌和益生元组合物 |
| CA2971108C (en) | 2014-12-23 | 2019-09-17 | 4D Pharma Research Limited | A bacteroides thetaiotaomicron strain and use thereof in reducing inflammation |
| HRP20180847T1 (hr) | 2014-12-23 | 2018-08-24 | 4D Pharma Research Limited | Pirinski polipeptid i imunološka modulacija |
| KR20170103804A (ko) * | 2015-01-16 | 2017-09-13 | 바이오가이아 에이비 | 젖산 세균 및 유방염의 치료를 위한 이들의 용도 |
| EP3250217A1 (en) * | 2015-01-30 | 2017-12-06 | Technische Universität München | Composition for use in preventing and/or treating diarrhea in animals |
| CA2980759A1 (en) | 2015-03-31 | 2016-10-06 | Gojo Industries, Inc. | Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| HUE045413T2 (hu) | 2015-06-15 | 2019-12-30 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| ES2753779T3 (es) | 2015-06-15 | 2020-04-14 | 4D Pharma Res Ltd | Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes |
| JP6439037B2 (ja) | 2015-06-15 | 2018-12-19 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | 細菌株を含む組成物 |
| SK542015A3 (sk) * | 2015-07-30 | 2017-02-02 | Univerzita Pavla Jozefa Šafárika V Košiciach | Kmene mikroorganizmov Lactobacillus Plantarum LS/07 CCM 7766 a spôsob ich využitia |
| HUE036362T2 (hu) | 2015-11-20 | 2018-07-30 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| CA3008175A1 (en) * | 2015-12-24 | 2017-06-29 | Dairy A Day Inc. | Compositions and methods of use of novel strains of lactobacillus fermentum |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| EP3520801A1 (en) | 2016-03-04 | 2019-08-07 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
| TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| MY199866A (en) * | 2017-01-13 | 2023-11-26 | Bened Biomedical Co Ltd | A novel lactic acid bacteria and its applications |
| CA3064171A1 (en) | 2017-05-22 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| EP3630942B1 (en) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
| JP2020523326A (ja) | 2017-06-14 | 2020-08-06 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | 細菌株を含む組成物 |
| SMT202100069T1 (it) | 2017-06-14 | 2021-03-15 | 4D Pharma Res Limited | Composizioni comprendenti ceppi batterici |
| JP6884889B2 (ja) | 2017-06-14 | 2021-06-09 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | 細菌株を含む組成物 |
| AU2019237674B2 (en) * | 2018-03-23 | 2023-06-08 | Morinaga Milk Industry Co., Ltd. | Composition for enhancing breast milk component |
| US20220184153A1 (en) * | 2019-03-25 | 2022-06-16 | The State of Israel, Ministry of Agriculture&Rural Development, Agricltural Research Oganization(ARO | Method of treating bovine mastitis |
| EP3996510A4 (en) * | 2019-07-08 | 2023-08-09 | BioPlx, Inc. | LIVING BIOTHERAPEUTIC COMPOSITIONS AND PROCESSES |
| EP4065146A1 (en) * | 2019-11-29 | 2022-10-05 | Société des Produits Nestlé S.A. | Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis |
| CL2019003739A1 (es) * | 2019-12-18 | 2020-06-19 | Univ Concepcion | Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos. |
| JP2022150100A (ja) * | 2021-03-26 | 2022-10-07 | 清竺 遠藤 | 乳汁の体細胞数減少用又は乳量増加用組成物 |
| CN117338823A (zh) * | 2023-12-06 | 2024-01-05 | 山东百德生物科技有限公司 | 一种动物酵素发酵液及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4591499A (en) | 1984-01-20 | 1986-05-27 | J. B. Lima, Inc. | Method for treatment and prevention of mastitis |
| ATE172245T1 (de) * | 1992-07-06 | 1998-10-15 | Nestle Sa | Milchbakterien |
| US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| WO2004003235A2 (en) * | 2002-06-28 | 2004-01-08 | Puleva Biotech, S.A. | Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| IE20030773A1 (en) * | 2003-10-17 | 2005-04-20 | Teagasc Agric Food Dev Authori | Use of probiotic bacteria in the treatment of infection |
| WO2005085287A1 (en) * | 2004-03-03 | 2005-09-15 | En-N-Tech, Inc. | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions |
| US7955834B2 (en) * | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
-
2007
- 2007-05-31 EP EP07380158A patent/EP1997499A1/en not_active Withdrawn
-
2008
- 2008-06-02 PT PT87603551T patent/PT2162143E/pt unknown
- 2008-06-02 CA CA2689360A patent/CA2689360C/en active Active
- 2008-06-02 HU HUE08760355A patent/HUE025851T2/en unknown
- 2008-06-02 PL PL08760355T patent/PL2162143T3/pl unknown
- 2008-06-02 DK DK08760355.1T patent/DK2162143T3/en active
- 2008-06-02 AU AU2008257455A patent/AU2008257455B2/en active Active
- 2008-06-02 US US12/602,182 patent/US8557560B2/en active Active
- 2008-06-02 ES ES08760355.1T patent/ES2555159T3/es active Active
- 2008-06-02 NZ NZ581576A patent/NZ581576A/en unknown
- 2008-06-02 EP EP08760355.1A patent/EP2162143B1/en active Active
- 2008-06-02 JP JP2010509847A patent/JP5710250B2/ja active Active
- 2008-06-02 RU RU2009149393/15A patent/RU2446814C2/ru active
- 2008-06-02 MX MX2009013044A patent/MX2009013044A/es active IP Right Grant
- 2008-06-02 WO PCT/EP2008/056768 patent/WO2008145756A1/en not_active Ceased
-
2009
- 2009-11-26 IL IL202386A patent/IL202386A0/en unknown
- 2009-12-30 CO CO09149368A patent/CO6270334A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010528093A5 (cg-RX-API-DMAC7.html) | ||
| RU2009149393A (ru) | Микроорганизмы молока млекопитающего, их содержащие композиции и их применение для лечения мастита | |
| CN111944727B (zh) | 一种短双歧杆菌207-1及其应用 | |
| EP3681470B1 (en) | Lactobacillus casei or lactobacillus paracasei for use in the treatment of clostridium difficile infections | |
| Bomba et al. | Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids | |
| JP4455333B2 (ja) | プロバイオティック細菌：Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍ | |
| RU2372788C2 (ru) | Пробиотическая стимулирующая здоровье или производительность кормовая добавка или добавка к питьевой воде, а также ее применение | |
| US11229672B2 (en) | Probiotics composition containing hericium erinaceus | |
| Kumari et al. | Probiotics, prebiotics, and synbiotics: Current status and future uses for human health | |
| JP2021522867A (ja) | ラクトバチルス・パラカゼイ株及びその使用 | |
| KR102024883B1 (ko) | 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도 | |
| KR20190008849A (ko) | 건선의 치료 및/또는 예방에서의 프로바이오틱스의 용도 | |
| KR20120125359A (ko) | 항알레르기용 조성물 | |
| CA3123125A1 (en) | Strains, composition and method of use | |
| CN112218646A (zh) | 一种组合物及其应用 | |
| Panesar et al. | Probiotics, prebiotics and synbiotics: opportunities, health benefits and industrial challenges | |
| US12150968B2 (en) | Method for reducing the transfer of pathogenic microorganisms | |
| CN112353822A (zh) | 一种乳酸乳球菌粒子与益生菌在制备抗幽门螺旋杆菌感染药物中的应用 | |
| Goel et al. | Probiotics: Microbial therapy for health modulation | |
| KR20180056896A (ko) | 한국인 모유로부터 분리한 락토바실러스 가세리 제이12피4 와 스타필로코커스 에피더미디스 제이4피1로 제조한 인공영양아용 미생물제제 및 이를 사용한 장염 억제 방법 | |
| CN104293689A (zh) | 一株高粘附力乳酸杆菌菌株及其应用 | |
| CN107836721A (zh) | 一种具有胃肠道保健功能的组合物及其制备方法 | |
| Dastoor et al. | Probiotics for life–Part I general health perspectives | |
| Konuray et al. | Antimicrobial Effect of Probiotics, Prebiotics, and Synbiotics | |
| Bhattacharyya | Emergence of probiotics in therapeutic applications |